Search results for "From ACP Journal Club"
DPP-4 inhibitors are less effective than metformin for reducing hemoglobin A1c
A meta-analysis of randomized controlled trials comparing dipeptidyl peptidase-4 (DPP-4) inhibitors to metformin and other drugs found that DPP-4 monotherapy is less effective.
https://diabetes.acponline.org/archives/2012/08/10/7.htm
10 Aug 2012
Bariatric surgery improved HbA1c at 5 y more than intensive medical care alone in obese patients with T2DM
A commentary considers the industry-funded STAMPEDE trial, in which obese patients with type 2 diabetes were randomly assigned to intensive medical therapy alone or intensive medical therapy plus Roux-en-Y gastric bypass or sleeve gastrectomy.
https://diabetes.acponline.org/archives/2017/06/09/6.htm
9 Jun 2017
Metformin reduced CV events compared with glipizide in patients with type 2 diabetes and CAD
A multicenter randomized controlled trial of Chinese patients with type 2 diabetes and coronary artery disease found that metformin reduced cardiovascular events more than glipizide at 5 years.
https://diabetes.acponline.org/archives/2013/05/10/10.htm
10 May 2013
Review: Long-term dual-antiplatelet therapy (DAPT) after PCI is no better than short-term DAPT, even with diabetes
Having diabetes was associated with higher risk of a major cardiovascular event after implementation of a drug-eluting stent, according to a systematic review.
https://diabetes.acponline.org/archives/2017/03/10/6.htm
10 Mar 2017
Review: Bariatric surgery increases weight loss and diabetes remission more than nonsurgical treatment
A meta-analysis of 11 randomized, controlled trials found that bariatric surgery improved several health and diabetes outcomes more than nonsurgical treatment.
https://diabetes.acponline.org/archives/2014/02/14/6.htm
14 Feb 2014
Review: Bariatric surgery improves weight and glycemia in nonmorbidly obese adults with diabetes
A review of 3 randomized controlled trials found that surgical treatment increased weight loss and improved diabetes-related outcomes more than nonsurgical treatment in moderately obese patients.
https://diabetes.acponline.org/archives/2013/11/08/7.htm
8 Nov 2013
Meta-analysis: Self-monitoring in non-insulin-treated type 2 diabetes improved HbA1c by 0.25%
A meta-analysis of randomized controlled trials of patients with non–insulin-treated type 2 diabetes found that six months of self-monitoring blood glucose reduced hemoglobin A1c levels by 0.25% more than usual care.
https://diabetes.acponline.org/archives/2012/07/13/8.htm
13 Jul 2012
Review: Quality improvement strategies reduce HbA1c, LDL cholesterol, and BP in diabetes
Researchers reviewed more than 140 randomized trials of quality improvement (QI) strategies for managing adult patients with diabetes.
https://diabetes.acponline.org/archives/2012/11/09/8.htm
9 Nov 2012
Review: In type 2 diabetes, GLP-1 agonists plus basal insulin reduce HbA1c without increasing hypoglycemia
Combination treatment with a glucagon-like peptide-1 receptor (GLP-1) agonist and basal insulin was associated with lower HbA1c values, less weight gain, and similar hypoglycemia rates compared to other type 2 diabetes treatment regimens, according to a meta-analysis.
https://diabetes.acponline.org/archives/2015/02/13/5.htm
13 Feb 2015
Review: Type 2 diabetes screening does not reduce mortality but treating dysglycemia delays onset of diabetes
A systematic evidence review by the U.S. Preventive Services Task Force found no evidence of mortality benefit from screening for diabetes, based on 2 large randomized controlled trials conducted in the United Kingdom.
https://diabetes.acponline.org/archives/2015/10/09/6.htm
9 Oct 2015